Neogen Statistics
Total Valuation
Neogen has a market cap or net worth of $2.18 billion. The enterprise value is $2.93 billion.
Important Dates
The next estimated earnings date is Tuesday, April 8, 2025, before market open.
| Earnings Date | Apr 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Neogen has 216.94 million shares outstanding. The number of shares has increased by 0.21% in one year.
| Current Share Class | 216.94M |
| Shares Outstanding | 216.94M |
| Shares Change (YoY) | +0.21% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.26% |
| Owned by Institutions (%) | 111.68% |
| Float | 198.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 19.88 |
| PS Ratio | 2.38 |
| Forward PS | 2.31 |
| PB Ratio | 0.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 115.37 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.21 |
| EV / EBITDA | 17.69 |
| EV / EBIT | 61.97 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.33.
| Current Ratio | 3.77 |
| Quick Ratio | 2.01 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 5.39 |
| Debt / FCF | n/a |
| Interest Coverage | 0.64 |
Financial Efficiency
Return on equity (ROE) is -16.38% and return on invested capital (ROIC) is 0.78%.
| Return on Equity (ROE) | -16.38% |
| Return on Assets (ROA) | 0.68% |
| Return on Invested Capital (ROIC) | 0.78% |
| Return on Capital Employed (ROCE) | 1.21% |
| Revenue Per Employee | $313,277 |
| Profits Per Employee | -$163,294 |
| Employee Count | 2,917 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 2.59 |
Taxes
| Income Tax | -28.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.80% in the last 52 weeks. The beta is 1.23, so Neogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | -41.80% |
| 50-Day Moving Average | 11.61 |
| 200-Day Moving Average | 14.44 |
| Relative Strength Index (RSI) | 34.46 |
| Average Volume (20 Days) | 2,196,021 |
Short Selling Information
The latest short interest is 20.09 million, so 9.26% of the outstanding shares have been sold short.
| Short Interest | 20.09M |
| Short Previous Month | 21.30M |
| Short % of Shares Out | 9.26% |
| Short % of Float | 10.10% |
| Short Ratio (days to cover) | 6.70 |
Income Statement
In the last 12 months, Neogen had revenue of $913.83 million and -$476.33 million in losses. Loss per share was -$2.20.
| Revenue | 913.83M |
| Gross Profit | 448.62M |
| Operating Income | 47.30M |
| Pretax Income | -14.31M |
| Net Income | -476.33M |
| EBITDA | 165.67M |
| EBIT | 47.30M |
| Loss Per Share | -$2.20 |
Full Income StatementBalance Sheet
The company has $140.38 million in cash and $893.56 million in debt, giving a net cash position of -$753.19 million or -$3.47 per share.
| Cash & Cash Equivalents | 140.38M |
| Total Debt | 893.56M |
| Net Cash | -753.19M |
| Net Cash Per Share | -$3.47 |
| Equity (Book Value) | 2.67B |
| Book Value Per Share | 12.30 |
| Working Capital | 419.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $18.88 million and capital expenditures -$111.97 million, giving a free cash flow of -$93.09 million.
| Operating Cash Flow | 18.88M |
| Capital Expenditures | -111.97M |
| Free Cash Flow | -93.09M |
| FCF Per Share | -$0.43 |
Full Cash Flow StatementMargins
Gross margin is 49.09%, with operating and profit margins of 5.18% and -52.12%.
| Gross Margin | 49.09% |
| Operating Margin | 5.18% |
| Pretax Margin | -55.20% |
| Profit Margin | -52.12% |
| EBITDA Margin | 18.13% |
| EBIT Margin | 5.18% |
| FCF Margin | n/a |
Dividends & Yields
Neogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.21% |
| Shareholder Yield | -0.21% |
| Earnings Yield | -21.87% |
| FCF Yield | -4.27% |
Dividend DetailsAnalyst Forecast
The average price target for Neogen is $14.00, which is 39.44% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 39.44% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 3.71% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 7, 2021. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2021 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Neogen has an Altman Z-Score of 1.9 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.9 |
| Piotroski F-Score | 5 |